WuXi Biologics

A comprehensive overview of WuXi Biologics, a leading global open-access biologics technology platform company.

Overview

WuXi Biologics is a leading global open-access biologics technology platform company that provides end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. The company is headquartered in Wuxi, China, and has a significant presence in the United States, Europe, and other regions.

History

Founded in 2010, WuXi Biologics has rapidly grown to become a key player in the biologics industry. The company was established as a subsidiary of WuXi AppTec, a well-known pharmaceutical, biotechnology, and medical device company. Over the years, WuXi Biologics has expanded its capabilities and facilities, establishing itself as a leader in the biologics contract development and manufacturing organization (CDMO) sector.

Services

WuXi Biologics offers a comprehensive range of services that cover the entire biologics development process. These services include:

• Discovery Services: WuXi Biologics provides integrated discovery services, including target validation, antibody generation, and lead optimization.
• Development Services: The company offers process development, analytical development, and formulation development services to ensure the successful transition from discovery to clinical trials.
• Manufacturing Services: WuXi Biologics operates state-of-the-art manufacturing facilities that support clinical and commercial production of biologics. The company is known for its single-use bioreactor technology and flexible manufacturing solutions.
• Quality Assurance: Ensuring the highest quality standards, WuXi Biologics provides comprehensive quality assurance and regulatory support to meet global compliance requirements.

Global Presence

WuXi Biologics has established a global network of facilities and offices to support its international clientele. The company operates multiple facilities in China, including its headquarters in Wuxi, as well as sites in Shanghai and Suzhou. In addition, WuXi Biologics has expanded its operations to include facilities in Ireland, Germany, and the United States, enhancing its ability to serve clients worldwide.

Innovation and Technology

WuXi Biologics is at the forefront of innovation in the biologics industry. The company invests heavily in research and development to advance its technology platforms. Key areas of innovation include:

• Single-Use Bioreactors: WuXi Biologics is a pioneer in the use of single-use bioreactor systems, which offer flexibility and efficiency in biologics manufacturing.
• Continuous Bioprocessing: The company is developing continuous bioprocessing technologies to improve production efficiency and reduce costs.
• Advanced Analytical Techniques: WuXi Biologics employs cutting-edge analytical techniques to ensure the quality and safety of biologics products.

Strategic Partnerships

WuXi Biologics has formed strategic partnerships with leading pharmaceutical and biotechnology companies to advance the development of innovative biologics. These collaborations enable the company to leverage its expertise and resources to accelerate the development of new therapies.

Gallery

• Logo of WuXi Biologics.png

  Logo of WuXi Biologics

• 

  WuXi Biologics Headquarters

Related pages

• Biologics
• Biotechnology
• Pharmaceutical industry
• Contract development and manufacturing organization